Forest Labs (FRX) Wins FDA Approval for COPD Treatment -Bloomberg
Tweet
Share
E-mailGet Alerts FRX Hot Sheet
Join SI Premium – FREE
Bloomberg reporting Forest Labs (NYSE: FRX) has won approval for its COPD treatment.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- MicroCloud Hologram acquires 140,268 MicroStrategy shares via structured note
- Two Harbors receives final approval for CrossCountry Mortgage merger
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
